Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'Synthetic' OR with Authors including 'Synthetic' OR with Abstract including 'Synthetic' OR with Keywords including 'Synthetic'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
HOCH PH Experimentally produced psychoses Am J Psychiatry 1951
Landis C, Clausen J Certain effects of mescaline and lysergic acid on psychological functi... J. Psychol. 1954
Burroughs W Letter From A Master Addict To Dangerous Drugs British Journal of A... 1956
EDDY NB, HALBACH H, BRAEN... Synthetic substances with morphine-like effect: clinical experience; p... Bull World Health Or... 1957
Cerletti A Biochemie, Physiologie und Pharmakologie des 5-Hydroxytryptamins (Sero... Helv. med. Acta 1958
Hladovec J, Votava Z The effect of ergot alkaloids, their partial synthetic derivatives and... Physiol. Bohemoslov. 1958
AVIADO DM, WNUCK AL, DE B... The effects of sympathomimetic drugs on renal vessels J Pharmacol Exp Ther 1958
Hofmann A, Troxler F Identifizierung von Psilocin Experientia 1959
Turner WJ, S Merlis Effects of some Indolealkylamines on Man A.M.A. Archives of N... 1959
Woolley DW Serotonin in mental disorders Dis.Nerv.System 1960
Leary T, Litwin GH, Metzn... Reactions to psilocybin administered in a supportive environment J. Nerv. Ment. Disea... 1963
Der Marderosian AH Nomenclatural History of the Morning Glory, Ipomoea violacea (L.) Taxon 1965
Smart RG, Bateman K Unfavourable reactions of LSD: a review and analysis of the available ... Canadian Medical Ass... 1967
Editorial Hallucinations to Order [in News and Views] Nature 1967
Agurell S, Lars J, Nilsso... A Biosynthetic Sequence from Tryptophan to Psilocybin Tetrahedron Letters 1968
Agurell S, Lundström J Apparent Intermediates in the Biosynthesis of Related Tetrahydroisoqui... Chemical Communicati... 1968
Schultes RE Hallucinogens of plant origin Science 1969
Agurell S Identification of alkaloid intermediates by gas chromatography-mass sp... Lloydia 1969
Schnoll SH, Vogel WH Analysis of street drugs N Engl J Med 1971
Grof S LSD and the Cosmic Game: Outline of Psychedelic Cosmology and Ontology Journal for the Stud... 1972
Shulgin AT Mescaline: the chemistry and pharmacology of its analogs Lloydia 1973
Lin CCL, Blair GE, Cassad... Biosynthesis of Ergot Alkaloids, Synthesis of 6-Methyl-8-acetoxymethyl... J.Org.Chem. 1973
Pascal JP, Vaysse N, Ader... The Mechanisms of Functional Vasodilation in the Pancreas : Digestion 1973
Stern P The influence of synthetic "Substance P" on tremor caused by LSD in mi... J. Pharm. Pharmacol. 1973
Caldwell J, Sever PS The biochemical pharmacology of abused drugs 1. Amphetamines, cocaine,... Clin.Pharmacol.Ther. 1974
del Castillo J, Anderson ... Marijuana, absinthe and the central nervous system Nature 1975
Shulgin AT, Helisten C Differentiation of PCP, TCP, and a contaminating precursor PCC, by thi... Microgram 1975
Gal J, Gruenke LD, Castag... N-Hydroxylation of 1-(2,5-demethoxy-4-methylphenyl)-2-aminopropane by ... J Med Chem 1975
Schultes RE Indole alkaloids in plant hallucinogens Planta Med 1976
Armstrong VW, Coulton S, ... A New Synthetic Route To {plus-minus) Lysergic Acid Tetrahedron Lett. 1976
Erni F, Frei RW, Lindner ... A Low-Cost Gradient System for High-Performance Liquid Chromatography.... J.Chromatog. 1976
Jantz L Probleme und Möglochkeiten ambulanter und stationäer Behandlune von Su... Therapiewoche 1976
Bury RW, Mashford ML A Pharmacological Investigation of Synthetic Substance P on the Isolat... Clin.Exp.Pharmacol.P... 1977
Hashimoto H, Hayashi M, N... Actions Of D-lysergic Acid Diethylamide (LSD) And Its Derivatives On 5... European Journal of ... 1977
Hasimoto H, Hayashi M, Na... Hyperthermic Effects of D-Lysergic Acid Diethylamide (LSD) and its Der... Arch. int. Pharmacod... 1977
Pardanani JH, McLaughlin ... Cactus Alkaloids. XXXVI. Mescaline and related compounds from Trichoce... Lloydia 1977
Winter JC Stimulus Properties of Phenethylamine Hallucinogens and Lysergic Acid ... J.Pharmacol.Exp.Ther... 1978
Fanchamps A Some Compounds With Hallucinogenic Activity Handbook of Experime... 1978
Keller HH, Burkard WP, Pi... Lisuride- and D-LSD-Induced Changes of Monoamine Turnover in the Rat B... Advances in Biochemi... 1978
Northup JK, Mansour TE Adenylate Cyclase from Fasciola Hepatica. 2. Role of Guanine Nucleotid... Molec. Pharmacol. 1978
Ranbom W Synthetic approaches to lysergic acid Diss. Abst. Intern. ... 1978
Kobel H, Sanglier JJ Ergot Alkaloids unknown 1978
Murdock JE, Shulgin AT A novel illicit amphetamine laboratory Microgram 1978
Hofmann A How LSD Originated Journal of Psychedel... 1979
Shulgin AT Chemistry of phenethylamines related to mescaline J Psychedelic Drugs 1979
Horowski R, Wachtel H Pharmacological Effects Of Lisuride In Rodents Mediated By Dopaminergi... Dopaminergic Ergot D... 1979
Mace S LSD CLINICAL TOXICOLOGY 1979
Schorderet M, Sovilla JY,... New Findings Related To A Possible Interaction Of Ergolines And Ergope... Progress in Neuro-Ps... 1980
Weingartner H, Gold P, Ba... Effects of vasopressin on human memory functions Science 1981
Luscombe G, Jenner P, Mar... Myoclonus In Guinea Pigs Is Induced By Indole-containing But Not Piper... Life Sciences 1982
Stadler PA Neuere Ergebnisse der Mutterkornalkaloid-Forschung New Results of Ergo... Journal of Medical P... 1982
Pieri L, Keller HH, Laure... Behavioral, Neurochemical, and Electrophysiological Effects of Lisurid... Lisuride and Other D... 1983
Ruffing DM, Domino EF Interaction of Synthetic Opioid Metenkephalin Peptide Analogs, Lilly ... Psychopharmacology 1983
Hofmann A, Goodwin DW LSD: My Problem Child-- Reflections on Sacred Drugs, Mysticism, and S... JAMA 1983
Knaus EE, Warren BK, Ondr... US Patent 4,468,403 : Analgesic Substituted Piperidylidine-2-sulfon(cy... USPTO 1984
Strassman RJ Adverse reactions to psychedelic drugs. A review of the literature J Nerv Ment Dis 1984
Ziporyn T A growing industry and menace: makeshift laboratory's designer drugs JAMA 1986
Dowling GP, McDonough ET ... 'Eve' and 'Ecstasy'. A report of five deaths associated with the use o... JAMA 1987
Buchanan JF, Brown CR 'Designer drugs'. A problem in clinical toxicology Med Toxicol Adverse ... 1988
Herkenham M, Lynn AB, Lit... Cannabinoid receptor localization in brain Proc Natl Acad Sci U... 1990
Duke JD Promising Phytomedicinals Advances in New Crop... 1990
Lim HK, Foltz RL In vivo formation of aromatic hydroxylated metabolites of 3,4-(methyle... Biol Mass Spectrom 1991
Doblin RE, Kleiman MA Marijuana as antiemetic medicine: a survey of oncologists' experiences... J Clin Oncol 1991
Preston A Pointing out the Risk Nursing Times 1992
Singarajah C, Lavies NG An overdose of ecstasy: A role for dantrolene Anaesthesia 1992
Nevilla GA, Beckstead HD,... USP Lysergic Acid Diethylamide Tartrate (LOT 1) Authentic Substance Re... Canadian Journal of ... 1992
Daly JW, Caceres J, Moni ... Frog secretions and hunting magic in the upper Amazon: identification ... Proc Natl Acad Sci U... 1992
Maxwell DL, Polkey MI, He... Hyponatraemia and catatonic stupor after taking 'ecstasy' BMJ 1993
Renton RJ, Cowie JS, Oon ... A study of the precursors, intermediates and reaction by-products in t... Forensic Sci Int 1993
Roberts L, Wright H Survival following intentional massive overdose of 'Ecstasy' J Accid Emerg Med 1993
Rothwell PM, Grant R Cerebral venous sinus thrombosis induced by 'ecstasy' J Neurol Neurosurg P... 1993
McDowell DM, Kleber HD MDMA: Its history and pharmacology Psychiatric Annals 1994
Malone MH, Rother A Heimia salicifolia: a phytochemical and phytopharmacologic review J Ethnopharmacol 1994
McCoy EP, Renfrew C, John... Malignant hyperpyrexia in an MDMA ('Ecstasy') abuser Ulster Med J 1994
Eich E, Pertz H Ergot alkaloids as lead structures for differential receptor systems Pharmazie 1994
Henderson GL, Harkey MR, ... Metabolism of 4-methylaminorex ('EU4EA') in the rat J Anal Toxicol 1995
Rudgley R The archaic use of hallucinogens in Europe: an archaeology of altered ... Addiction 1995
Bryden AA, Rothwell PJ, O... Urinary retention with misuse of 'ecstasy' BMJ 1995
Freeman RC, French JF What is the addicts' grapevine when there's 'bad dope'? An investigati... Public Health Rep 1995
Rezvani K, Kurbaan AS, Br... Ecstasy induced pneumomediastinum Thorax 1996
Matthai SM, Davidson DC, ... Cerebral oedema after ingestion of MDMA ('ecstasy') and unrestricted i... BMJ 1996
McKenna DJ Plant hallucinogens: springboards for psychotherapeutic drug discovery Behav Brain Res 1996
Schwartz RH, Voth EA, She... Marijuana to prevent nausea and vomiting in cancer patients: a survey ... South Med J 1997
Brauer RB, Heidecke CD, N... Liver transplantation for the treatment of fulminant hepatic failure i... Transpl Int 1997
Hussain, G. and Manyam, B... Mucuna pruriens Proves More Effective than L-DOPA in Parkinson's Disea... Phytotherapy Researc... 1997
Gallily R, Yamin A, Waksm... Protection against septic shock and suppression of tumor necrosis fact... J Pharmacol Exp Ther 1997
Andreu V, Mas A, Bruguera... Ecstasy: a common cause of severe acute hepatotoxicity J Hepatol 1998
Smith FL, Cichewicz D, Ma... The enhancement of morphine antinociception in mice by delta9-tetrahyd... Pharmacol Biochem Be... 1998
Gessa GL, Casu MA, Carta ... Cannabinoids decrease acetylcholine release in the medial-prefrontal c... Eur J Pharmacol 1998
Gessa GL, Casu MA, Carta ... Cannabinoids decrease acetylcholine release in the medial-prefrontal c... Eur J Pharmacol 1998
Schwab M, Seyringer E, Br... Fatal MDMA intoxication Lancet 1999
Stein DJ, Rink J Effects of 'Ecstasy' blocked by serotonin reuptake inhibitors J Clin Psychiatry 1999
Navarro JF, Maldonado E Behavioral profile of 3,4-methylenedioxy-methamphetamine (MDMA) in ago... Prog Neuropsychophar... 1999
Nagayama T, Sinor AD, Sim... Cannabinoids and neuroprotection in global and focal cerebral ischemia... J Neurosci 1999
Ito K [Studies on the alkaloids of Erythrina plants] Yakugaku Zasshi 1999
McFee RB, Mofenson HC, Ca... Dextromethorphan: Another 'Ecstasy'? Arch Fam Med 2000
van Aerts LAGJM, Malleret... N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties ... Addiction Biology 2000
Sinor AD, Irvin SM, Green... Endocannabinoids protect cerebral cortical neurons from in vitro ische... Neurosci Lett 2000
de la Torre R, Farré M, O... Non-linear pharmacokinetics of MDMA (`ecstasy') in humans Br J Clin Pharmacol 2000
de la Torre R, Farre M, O... Non-linear pharmacokinetics of MDMA ('ecstasy') in humans Br J Clin Pharmacol 2000

Page 1 of 4   /   337 Entries Returned
Pages:     
 1 
2 3 4 next